LOX: Catheters, Transluminal Coronary Angioplasty, Percutaneous

Product code LOX, “Catheters, Transluminal Coronary Angioplasty, Percutaneous” in FDA's classification database, is a Class II device type under 21 CFR 870.5100 (percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 88 clearances under LOX, 82 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
LOX
Regulation
21 CFR 870.5100
Class
II
Panel
Cardiovascular
Clearances
88
Most recent
Aug 14, 2026
Median review, last 2 years
156 days
Third-party review
Not eligible
Implant
No

What it covers

A PTCA catheter is a device that operates on the principle of hydraulic pressurization applied through an inflatable balloon attached to the distal end.

FDA’s definition of product code LOX, from the Product Classification database.

Recent clearances

510(k)DeviceApplicantDecisionType
K261428NC Euphora Rapid Exchange Balloon Dilatation CatheterMedtronic IrelandAug 14, 2026Traditional
K261759Euphora Rapid Exchange (RX) Balloon Dilatation CatheterMedtronic IrelandJul 27, 2026Traditional
K252116Firefighter™ Pro PTCA Balloon CatheterShanghai MicroPort Medical (Group) Co., Ltd.Apr 7, 2026Traditional
K254022FLASH Flex™ Aorto-Ostial Angioplasty SystemVerge Medical, Inc.Apr 2, 2026Traditional
K252295RyureiTerumo CorporationMar 27, 2026Traditional
K251970Sprinter Legend Rapid Exchange Balloon Dilatation CatheterMedtronic, IrelandJan 17, 2026Traditional
K242969Pantera Pro; Pantera LEOBiotronik, Inc.Oct 25, 2024Special
K233499Sapphire NC ULTRA Coronary Dilatation CatheterOrbusNeich Medical (Shenzhen) Co., Ltd.Aug 16, 2024Traditional
K233505Sapphire ULTRA Coronary Dilatation CatheterOrbusNeich Medical (Shenzhen) Co., Ltd.Aug 15, 2024Traditional
K233729Ringer perfusion balloon catheter, 2.00 x 20mm (5881); Ringer perfusion balloon catheter, 2.50 x 20mm (5882); Ringer perfusion balloon catheter, 2.50 x 30mm (5883); Ringer perfusion balloon catheter, 3.00 x 20mm (5884); Ringer perfusion balloon catheter, 3.00 x 30mm (5885); Ringer perfusion balloon catheter, 3.50 x 20mm (5886); Ringer perfusion balloon catheter, 3.50 x 30mm (5887); Ringer perfusion balloon catheter, 4.00 x 20mm (5888); Ringer perfusion balloon catheter, 4.00 x 30mm (58Vascular Solutions, LLCMay 31, 2024Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 88 with a free account)

Clearances by year

82 LOX 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)6156
20244241
20234138
20225121
20216167
2020129
2019121
2018780
20176113
20169116
20154119
20146166
20136123
201210120
20117103

Who submits

34 applicants cleared a LOX device since 2011. 57% of the clearances went to applicants in United States, then China (23%), Ireland (7%) and Japan (5%). By type: Traditional 76% and Special 24%.

ApplicantClearances since 2011
Abbott Vascular6
Boston Scientific Corporation6
Ostial Corporation5
Orbusneich Medical Trading, Inc.4
Orbusneich Medical, Inc.4
Biotronik, Inc.3
Boston Scientific Corp3
Brosmed Medical Co., Ltd.3

How FDA classifies it

(b) Cutting/scoring PTCA Catheter—(1) Identification. A cutting/scoring PTCA catheter is a balloon-tipped catheter with cutting/scoring elements attached, which is used in those circumstances where a high pressure balloon resistant lesion is encountered. A cutting/scoring PTCA catheter is intended for the treatment of hemodynamically significant coronary artery stenosis for the purpose of improving myocardial perfusion. A cutting/scoring PTCA catheter may also be indicated for use in complex type C lesions or for the treatment of in-stent restenosis.

(2) Classification. Class III (premarket approval). As of May 28, 1976, an approval under section 515 of the act is required before this device may be commercially distributed. See § 870.3.

From 21 CFR 870.5100. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 870.5100 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LOX clearances declared.

Ask about LOX

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about LOX

What is FDA product code LOX?

Product code LOX, “Catheters, Transluminal Coronary Angioplasty, Percutaneous” in FDA's classification database, is a Class II device type under 21 CFR 870.5100 (percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 88 clearances under LOX, 82 of them since 2011.

How many 510(k) clearances are there under LOX?

FDA’s 510(k) database listed 88 clearances under LOX as of Oct 29, 2026, 82 of them decided since 2011; the most recent decision was Aug 14, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a LOX 510(k)?

For the 6 LOX clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 156 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most LOX clearances?

Since 2011: Abbott Vascular (6), Boston Scientific Corporation (6), Ostial Corporation (5), Orbusneich Medical Trading, Inc. (4) and Orbusneich Medical, Inc. (4). 34 applicants have cleared a LOX device in that time.

Sources

  1. FDA product classification: LOX · Product Classification database
  2. 21 CFR 870.5100: Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for LOX · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow LOXGet an email when FDA clears, recalls or publishes guidance for LOX devices.

Know what FDA already cleared.